✦ LIBER ✦

[Annual Reports in Medicinal Chemistry] Volume 48 || Orexin Receptor Antagonists in Development for Insomnia and CNS Disorders

✍ Scribed by Kuduk, Scott D.

Book ID: 121258729
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 597 KB
Category: Article
ISBN: 0124171508
ISSN: 0065-7743
DOI: 10.1016/B978-0-12-417150-3.00006-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Volume 48 || Discovery and Development of Prolylcarboxypeptidase Inhibitors for Cardiometabolic Disorders

✍ Scarry, Sarah Chajkowski 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 441 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Volume 45 || Opioid Receptor Antagonists for Gastrointestinal Dysfunction

✍ Hipkin, R. William 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 327 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Volume 48 || Recent Advances in the Discovery and Development of CCR1 Antagonists

✍ Zhang, Penglie 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 321 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Annual Reports in Medicinal Chemistry Volume 47 Volume 47 || mGluR2 Activators and mGluR5 Blockers Advancing in the Clinic for Major CNS Disorders

✍ Célanire, Sylvain 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 503 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Volume 43 || Glucagon Receptor Antagonists for Type II Diabetes

✍ DeMong, Duane E. 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 193 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Annual Reports in Medicinal Chemistry Volume 46 Volume 46 || Recent Advances in the Discovery and Development of CRTh2 Antagonists

✍ Burgess, Laurence E. 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 887 KB

*Annual Reports in Medicinal Chemistry* provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.